Surgeons using Prevena Therapy for cardiothoracic surgery

Prevena Central for cardiothoracic surgery

The Power to Protect with 3M™ Prevena™ Therapy

Request a Trial
  • Icon depicting 75%

    Reduced rate of SSI compared to standard of care1

    90-day post-operatively
    4% (3/75) Prevena Therapy vs.
    16% (12/75) SOC (p=0.0266)*

  • Icon depicting 90%

    Reduced rate of wound infection with gram-positive skin flora1,*

    90-day post-operatively
    1.3% (1/75) Prevena Therapy vs.
    13.3% (10/75) SOC (p=0.0090)*

  • Icon depicting 99%

    Primary wound closure at day 6/7 on removal2*

    30-day post-operatively
    98.7% (234/237) Prevena Therapy

  • Calculations are derived based on relative patient group incidence rate reported in this study.

    *Statistically significant (p<0.05).

Proactive Risk Management (PRM) with Prevena Therapy

Implement PRM to help protect your high-risk patients. See the evidence behind the use of Prevena Therapy in cardiothoracic surgery.

  • Prevena Therapy is supported by more than 200 peer reviewed publications, with more being published every year. Download our easy to digest summary of the relevant clinical and health economic evidence to support the use of Prevena Therapy in cardiothoracic surgery.

  • Prevena Restor Arthro•Form Cases
    Patient and procedure risk stratification

    Prevena Therapy can benefit all surgical patients—but choosing Prevena Therapy for your high-risk patients can lead to improved outcomes and significant cost savings. Our Proactive Risk Management (PRM) guides will help you to select the right patients, and the right procedures , helping you to optimise outcomes.

  • Prevena Restor Arthro•Form Cases
    Clinical compendium

    With over 200 peer reviewed publications studying Prevena Therapy, there is now sufficient evidence to provide evidence-based guidance to help support surgeon’s decision making.

    Download the clinical compendium

purple banner

Request a trial today

Contact us to request a trial and consultation with a 3M clinical specialist


Surgeon testimonials

  • A clinician's hands holding the Prevena 125 Therapy Unit above a patient's abdomen
    Dr V. Seenu Reddy, Cardiothoracic Surgeon, describes how Prevena Therapy is helping to support enhanced recovery protocols for higher risk patients in his practice.

Application videos

Dark blue banner

Ready to try Prevena Therapy?

  • Thank you for your request to 3M. The information you provide on this form will be used to respond to your request through email or telephone by a 3M representative or by one of our authorised business partners with whom we might share your personal information consistent with the 3M privacy policy.
  • Please provide your information about your professional interest as we'd like to make sure you only recieve information from 3M that is interesting and relevant to you

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

Our apologies...

An error has occurred while submitting. Please try again later...

Thank you!

Your form was submitted successfully

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.


  1. Grauhan O, et al. Prevention of post sternotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
  2. Grauhan O, et al. Effect of surgical incision management on wound infections in a post sternotomy patient population. Int Wound J. 2014;11:6-9.